Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats

Epirubicin is a chemotherapy agent for hepatocellular carcinoma (HCC). However, the outcome of HCC patients receiving epirubicin remains unsatisfactory. Moreover, our previous study indicated that celecoxib suppresses HCC progression and liver cancer stemness. This study evaluated the potential of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Tian‐Huei, Chan, Hoi‐Hung, Hu, Tsung‐Hui, Wang, E‐Ming, Ma, Yi‐Ling, Huang, Shih‐Chung, Wu, Jian‐Ching, Chang, Yi‐Chen, Weng, Wen‐Tsan, Wen, Zhi‐Hong, Wu, Deng‐Chyang, Chen, Yi‐Ming Arthur, Tai, Ming‐Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010827/
https://www.ncbi.nlm.nih.gov/pubmed/29683262
http://dx.doi.org/10.1002/cam4.1487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010827/
https://www.ncbi.nlm.nih.gov/pubmed/29683262
http://dx.doi.org/10.1002/cam4.1487

Ejemplares similares